269 related articles for article (PubMed ID: 15769553)
21. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.
Singh JB; Zarate CA
Bipolar Disord; 2006 Dec; 8(6):696-709. PubMed ID: 17156156
[TBL] [Abstract][Full Text] [Related]
22. Bipolar rapid cycling: focus on depression as its hallmark.
Calabrese JR; Shelton MD; Bowden CL; Rapport DJ; Suppes T; Shirley ER; Kimmel SE; Caban SJ
J Clin Psychiatry; 2001; 62 Suppl 14():34-41. PubMed ID: 11469674
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorder.
Lieberman DZ; Kolodner G; Massey SH; Williams KP
J Addict Dis; 2009 Oct; 28(4):348-55. PubMed ID: 20155604
[TBL] [Abstract][Full Text] [Related]
24. Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Nunes EV; McGrath PJ; Quitkin FM; Ocepek-Welikson K; Stewart JW; Koenig T; Wager S; Klein DF
Drug Alcohol Depend; 1995 Oct; 39(3):185-95. PubMed ID: 8556967
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
Wobrock T; Soyka M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
[TBL] [Abstract][Full Text] [Related]
26. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
Mukai Y; Tampi RR
Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
[TBL] [Abstract][Full Text] [Related]
27. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
28. Does comorbid alcohol and substance abuse affect electroconvulsive therapy outcome in the treatment of mood disorders?
Moss L; Vaidya N
J ECT; 2014 Mar; 30(1):22-5. PubMed ID: 23859979
[TBL] [Abstract][Full Text] [Related]
29. Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis.
Fluyau D; Mitra P; Jain A; Kailasam VK; Pierre CG
Eur J Clin Pharmacol; 2022 Jun; 78(6):931-942. PubMed ID: 35246699
[TBL] [Abstract][Full Text] [Related]
30. Tricyclic antidepressants in the treatment of alcoholism and drug abuse.
Weiss RD; Mirin SM
J Clin Psychiatry; 1989 Jul; 50 Suppl():4-9; discussion 9-11. PubMed ID: 2661551
[TBL] [Abstract][Full Text] [Related]
31. Clinical practice guideline on pharmacological and psychological management of adult patients with depression and a comorbid substance use disorder.
Torrens M; Tirado-Muñoz J; Fonseca F; Farré M; González-Pinto A; Arrojo M; Bernardo M; Arranz B; Garriga M; Sáiz PA; Flórez G; Goikolea JM; Zorrilla I; Cunill R; Castells X; Becoña E; López A; San L
Adicciones; 2022 Apr; 34(2):128-141. PubMed ID: 33768269
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional volumetric analysis of brain atrophy in alcohol dependence: effects of drinking history and comorbid substance use disorder.
Bjork JM; Grant SJ; Hommer DW
Am J Psychiatry; 2003 Nov; 160(11):2038-45. PubMed ID: 14594753
[TBL] [Abstract][Full Text] [Related]
33. Paradoxes of evidence in Russian addiction medicine.
Mendelevich VD; Zalmunin KY
Int J Risk Saf Med; 2015; 27 Suppl 1():S102-3. PubMed ID: 26639682
[TBL] [Abstract][Full Text] [Related]
34. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
35. Depressive disorders and comorbidity: somatic illness vs. side effect.
Uzun S; Kozumplik O; Topić R; Jakovljević M
Psychiatr Danub; 2009 Sep; 21(3):391-8. PubMed ID: 19794363
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy of dual substance abuse and dependence.
Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
[TBL] [Abstract][Full Text] [Related]
37. Are antidepressants overrated? A review of methodological problems in antidepressant trials.
Moncrieff J
J Nerv Ment Dis; 2001 May; 189(5):288-95. PubMed ID: 11379971
[TBL] [Abstract][Full Text] [Related]
38. Comorbid depression and anxiety spectrum disorders.
Gorman JM
Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
[TBL] [Abstract][Full Text] [Related]
39. Commentary on Zhou et al. (2015): Treating psychiatric comorbidity in adolescents--an important problem.
Nunes EV
Addiction; 2015 Jan; 110(1):49-50. PubMed ID: 25515829
[No Abstract] [Full Text] [Related]
40. The integration of pharmacological therapy for comorbid psychiatric and addictive disorders.
Miller NS; Guttman JC
J Psychoactive Drugs; 1997; 29(3):249-54. PubMed ID: 9339856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
